Golimumab, SCH 900259, MK-8259, CNTO-148: A Comparative Review This assessment reviews four distinct therapies : golimumab, SCH 900259, MK-8259, and CNTO-148. Golimumab, a recognized antibody targeting TNF-alpha, https://www.targetmol.com/compound/golimumab